Drug
Placebo (0,9% NaCl solution)
Placebo (0,9% NaCl solution) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph early_phase_1
2
67%
Ph phase_2
1
33%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Early Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedearly_phase_1
The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)
NCT05919992
terminatedphase_2
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
NCT04536350
completedearly_phase_1
Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals
NCT05167084
Clinical Trials (3)
Showing 3 of 3 trials
NCT05919992Early Phase 1
The Role of Glucocorticoids to Maintain Energy Homeostasis During Starvation (Gluco-Starve)
NCT04536350Phase 2
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
NCT05167084Early Phase 1
Acute Consequences Of Food-induced Glucocorticoid Secretion In Healthy Individuals
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3